Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Center Looking To FY 2000 Appropriations To Reverse Decline In FTEs

This article was originally published in The Gray Sheet

Executive Summary

FDA's Center for Devices and Radiological Health lost 46 full-time equivalents (FTEs) between fiscal years 1997 and1998, and the center expects the total number to continue to decline, CDRH Director David Feigal reported during a July 21 Food & Drug Law Institute videoconference.

You may also be interested in...



"Stratified" 510(k) Review Tracks Might Result From CDRH Resource Crunch

FDA's Center for Devices and Radiological Health is considering whether or not to "stratify" 510(k) submissions into "high-priority" and "low-priority" categories that would have different review timeframes, CDRH Director David Feigal said.

"Stratified" 510(k) Review Tracks Might Result From CDRH Resource Crunch

FDA's Center for Devices and Radiological Health is considering whether or not to "stratify" 510(k) submissions into "high-priority" and "low-priority" categories that would have different review timeframes, CDRH Director David Feigal said.

FDA Sentinel Program Increases Adverse Event Reporting By User Facilities

The average level of medical device adverse event reporting increased significantly under FDA's one-year Sentinel feasibility study concluded last year, according to a report submitted June 16 by Coda, the contractor organization facilitating the pilot.

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel